Trial reportEuropean journal of applied physiology2025
The effects of acute and chronic oral tea catechins and ornithine supplementation on exercise-induced ammonia accumulation and cycling performance in healthy young men: a randomized, double-blind, cross-over, placebo-controlled trial.
Trial report in European journal of applied physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study examined the effects of acute and chronic oral intake of tea catechins and ornithine supplementation on exercise-induced ammonia accumulation and cycling performance.
methodsSixteen healthy young men participated in a randomized, double-blind, cross-over, placebo-controlled study. For the acute trials, the participants consumed either tea catechins and ornithine (CO) or placebo (P) and performed cycling exercises at an intensity corresponding to 75% of the maximum heart rate for 60 min, followed by a 15-min cycling performance test. The participants continued to consume each designated supplement for 13 days. For the chronic trials, the participants repeated the same protocol as the acute trials on day 14. After a washout period, the participants changed the supplement and repeated the same protocol as above.
resultsPlasma catechins (acute ES = 3.61; chronic ES = 2.64, p < 0.001) and ornithine (acute ES = 4.28; chronic ES = 2.25, p < 0.001) concentrations were higher in both acute and chronic CO trials than those in P trials. No differences were found in plasma ammonia concentration measured during the whole experimental period and in mean power output during the performance test among trials. Subjective fatigue during 60-min cycling was lower in both acute and chronic CO trials than those in P trials (acute ES = 0.32, chronic ES = 0.60, p < 0.001).
conclusionsA single dose and 14-day oral intake of tea catechins and ornithine supplementation did not suppress exercise-induced ammonia accumulation or enhance cycling performance. CLINICAL TRIAL: Clinical trial registration ID: UMIN000035267.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.